Cereproforce (Choline alfoscerate) 250 mg ampoules

Instructions for Cereproforce (Choline alfoscerate) 250 mg ampoules

Dosage form
Transparent colorless or slightly yellowish solution

Composition
per 1 ml:

Active substance Choline alfoscerate:

Choline alfoscerate (in terms of anhydrous substance) - 250.0 mg;
Auxiliary substance: water for injection - up to 1.0 ml

Pharmacotherapy group
nootropic agent

Pharmacodynamics
Choline alfoscerate is a central-acting cholinomymetic with a predominant effect on the central nervous system.

Testimony Choline alfoscerate

• Cerebral circulation disorders by ischemic type (acute and restorative period) and haemorrhagic type (restorative period).
• Psychoorganic syndrome against the background of involutive and degenerative processes of the brain.
• Effects of cerebrovascular insufficiency or primary and secondary cognitive impairment in the elderly, characterized by memory
• impairment, confusion, disorientation, decreased motivation and initiative, decreased concentration of attention.
• Disturbance of behavior and affective sphere in old age: emotional lability, increased irritability, decreased interest; senile
• pseudo-melancholy.
• Multi-infarction dementia.

Method of use and doses

Intravenous (droplet) or intramuscularly (slow) in dose
A thousand milligrams per day.